Key Insights

Highlights

Treatment Research

4 treatments under study, led by Placeo

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT03855202Phase 1Unknown

The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in Preterms

Showing all 1 trials

Research Network

Common Treatments

  • Placeo1
  • Ps1
  • Cbmnc1
  • Pscbmnc1

Active Sponsors

  • yangjie1

Top Investigators

Related Conditions

  • Neonates Premature1

Activity Timeline